<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" media="screen" href="/~d/styles/rss2full.xsl"?><?xml-stylesheet type="text/css" media="screen" href="http://feeds.feedburner.com/~d/styles/itemcontent.css"?><rss xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:wfw="http://wellformedweb.org/CommentAPI/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:sy="http://purl.org/rss/1.0/modules/syndication/" xmlns:slash="http://purl.org/rss/1.0/modules/slash/" xmlns:feedburner="http://rssnamespace.org/feedburner/ext/1.0" version="2.0"><channel><title>European Pharmaceutical Review</title> <link>http://www.europeanpharmaceuticalreview.com</link> <description /> <lastBuildDate>Fri, 03 Feb 2012 08:56:11 +0000</lastBuildDate> <language>en</language> <sy:updatePeriod>hourly</sy:updatePeriod> <sy:updateFrequency>1</sy:updateFrequency> <generator>http://wordpress.org/?v=3.3.1</generator> <atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="self" type="application/rss+xml" href="http://feeds.feedburner.com/EuropeanPharmaceuticalReview" /><feedburner:info uri="europeanpharmaceuticalreview" /><atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="hub" href="http://pubsubhubbub.appspot.com/" /><feedburner:emailServiceId>EuropeanPharmaceuticalReview</feedburner:emailServiceId><feedburner:feedburnerHostname>http://feedburner.google.com</feedburner:feedburnerHostname><feedburner:feedFlare href="http://add.my.yahoo.com/rss?url=http%3A%2F%2Ffeeds.feedburner.com%2FEuropeanPharmaceuticalReview" src="http://us.i1.yimg.com/us.yimg.com/i/us/my/addtomyyahoo4.gif">Subscribe with My Yahoo!</feedburner:feedFlare><feedburner:feedFlare href="http://fusion.google.com/add?feedurl=http%3A%2F%2Ffeeds.feedburner.com%2FEuropeanPharmaceuticalReview" src="http://buttons.googlesyndication.com/fusion/add.gif">Subscribe with Google</feedburner:feedFlare><feedburner:feedFlare href="http://www.live.com/?add=http%3A%2F%2Ffeeds.feedburner.com%2FEuropeanPharmaceuticalReview" src="http://tkfiles.storage.msn.com/x1piYkpqHC_35nIp1gLE68-wvzLZO8iXl_JMledmJQXP-XTBOLfmQv4zhj4MhcWEJh_GtoBIiAl1Mjh-ndp9k47If7hTaFno0mxW9_i3p_5qQw">Subscribe with Live.com</feedburner:feedFlare><item><title>FDA approves JANUMET® XR (sitagliptin and metformin HCl extended-release) for type 2 diabetes</title><link>http://feedproxy.google.com/~r/EuropeanPharmaceuticalReview/~3/lmu3affLZA0/</link> <comments>http://www.europeanpharmaceuticalreview.com/11017/news/industry-news/fda-approves-janumet-xr-sitagliptin-and-metformin-hcl-extended-release-for-type-2-diabetes/#comments</comments> <pubDate>Thu, 02 Feb 2012 16:51:00 +0000</pubDate> <dc:creator>pmccartney</dc:creator> <category><![CDATA[Industry news]]></category> <category><![CDATA[News]]></category> <category><![CDATA[Barry J. Goldstein]]></category> <category><![CDATA[Merck]]></category><guid isPermaLink="false">http://www.europeanpharmaceuticalreview.com/?p=11017</guid> <description>JANUMET XR can help many patients reach blood sugar goals...&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/EuropeanPharmaceuticalReview?a=lmu3affLZA0:DfTeQycf-Uw:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/EuropeanPharmaceuticalReview?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/EuropeanPharmaceuticalReview?a=lmu3affLZA0:DfTeQycf-Uw:qj6IDK7rITs"&gt;&lt;img src="http://feeds.feedburner.com/~ff/EuropeanPharmaceuticalReview?d=qj6IDK7rITs" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/EuropeanPharmaceuticalReview/~4/lmu3affLZA0" height="1" width="1"/&gt;</description> <wfw:commentRss>http://www.europeanpharmaceuticalreview.com/11017/news/industry-news/fda-approves-janumet-xr-sitagliptin-and-metformin-hcl-extended-release-for-type-2-diabetes/feed/</wfw:commentRss> <slash:comments>0</slash:comments> <feedburner:origLink>http://www.europeanpharmaceuticalreview.com/11017/news/industry-news/fda-approves-janumet-xr-sitagliptin-and-metformin-hcl-extended-release-for-type-2-diabetes/</feedburner:origLink></item> <item><title>AstraZeneca to cut a further 7,300 jobs</title><link>http://feedproxy.google.com/~r/EuropeanPharmaceuticalReview/~3/M_93Sr-Pg9M/</link> <comments>http://www.europeanpharmaceuticalreview.com/10990/news/industry-news/astrazeneca-to-cut-a-further-7300-jobs/#comments</comments> <pubDate>Thu, 02 Feb 2012 09:59:33 +0000</pubDate> <dc:creator>pmccartney</dc:creator> <category><![CDATA[Industry news]]></category> <category><![CDATA[News]]></category> <category><![CDATA[AstraZeneca]]></category> <category><![CDATA[David Brennan]]></category> <category><![CDATA[Martin Mackay]]></category><guid isPermaLink="false">http://www.europeanpharmaceuticalreview.com/?p=10990</guid> <description>AstraZeneca has announced new restructuring initiatives designed to improve productivity...&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/EuropeanPharmaceuticalReview?a=M_93Sr-Pg9M:gk2FnZt1jWs:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/EuropeanPharmaceuticalReview?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/EuropeanPharmaceuticalReview?a=M_93Sr-Pg9M:gk2FnZt1jWs:qj6IDK7rITs"&gt;&lt;img src="http://feeds.feedburner.com/~ff/EuropeanPharmaceuticalReview?d=qj6IDK7rITs" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/EuropeanPharmaceuticalReview/~4/M_93Sr-Pg9M" height="1" width="1"/&gt;</description> <wfw:commentRss>http://www.europeanpharmaceuticalreview.com/10990/news/industry-news/astrazeneca-to-cut-a-further-7300-jobs/feed/</wfw:commentRss> <slash:comments>0</slash:comments> <feedburner:origLink>http://www.europeanpharmaceuticalreview.com/10990/news/industry-news/astrazeneca-to-cut-a-further-7300-jobs/</feedburner:origLink></item> <item><title>FDA approves Novartis drug Glivec® label</title><link>http://feedproxy.google.com/~r/EuropeanPharmaceuticalReview/~3/7BaY6InQtGg/</link> <comments>http://www.europeanpharmaceuticalreview.com/10984/news/industry-news/fda-approves-novartis-drug-glivec-label-recommending-extending-treatment-to-three-years-for-certain-gist-patients-after-surgery/#comments</comments> <pubDate>Wed, 01 Feb 2012 11:58:28 +0000</pubDate> <dc:creator>pmccartney</dc:creator> <category><![CDATA[Industry news]]></category> <category><![CDATA[News]]></category> <category><![CDATA[Food and Drug Administration (FDA)]]></category> <category><![CDATA[Hervé Hoppenot]]></category> <category><![CDATA[Novartis]]></category><guid isPermaLink="false">http://www.europeanpharmaceuticalreview.com/?p=10984</guid> <description>The US Food and Drug Administration has approved an update to the Glivec® (imatinib)* label...&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/EuropeanPharmaceuticalReview?a=7BaY6InQtGg:M1LhvPBiUqY:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/EuropeanPharmaceuticalReview?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/EuropeanPharmaceuticalReview?a=7BaY6InQtGg:M1LhvPBiUqY:qj6IDK7rITs"&gt;&lt;img src="http://feeds.feedburner.com/~ff/EuropeanPharmaceuticalReview?d=qj6IDK7rITs" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/EuropeanPharmaceuticalReview/~4/7BaY6InQtGg" height="1" width="1"/&gt;</description> <wfw:commentRss>http://www.europeanpharmaceuticalreview.com/10984/news/industry-news/fda-approves-novartis-drug-glivec-label-recommending-extending-treatment-to-three-years-for-certain-gist-patients-after-surgery/feed/</wfw:commentRss> <slash:comments>0</slash:comments> <feedburner:origLink>http://www.europeanpharmaceuticalreview.com/10984/news/industry-news/fda-approves-novartis-drug-glivec-label-recommending-extending-treatment-to-three-years-for-certain-gist-patients-after-surgery/</feedburner:origLink></item> <item><title>Whitepaper: Autoantibody biomarker panels for improved disease diagnosis</title><link>http://feedproxy.google.com/~r/EuropeanPharmaceuticalReview/~3/W3MGMxoeTQY/</link> <comments>http://www.europeanpharmaceuticalreview.com/10977/whitepapers/whitepaper-autoantibody-biomarker-panels-for-improved-disease-diagnosis/#comments</comments> <pubDate>Wed, 01 Feb 2012 09:46:26 +0000</pubDate> <dc:creator>pmccartney</dc:creator> <category><![CDATA[Whitepapers]]></category> <category><![CDATA[Biomarkers]]></category> <category><![CDATA[Oxford Gene Technology (OGT)]]></category><guid isPermaLink="false">http://www.europeanpharmaceuticalreview.com/?p=10977</guid> <description>Download this free white paper for detailed insight into the advantages of autoantibodies as biomarkers, including a review of the current technology and best practices for identification of sensitive and specific autoantibody biomarkers.&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/EuropeanPharmaceuticalReview?a=W3MGMxoeTQY:uLYm0qjtLbs:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/EuropeanPharmaceuticalReview?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/EuropeanPharmaceuticalReview?a=W3MGMxoeTQY:uLYm0qjtLbs:qj6IDK7rITs"&gt;&lt;img src="http://feeds.feedburner.com/~ff/EuropeanPharmaceuticalReview?d=qj6IDK7rITs" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/EuropeanPharmaceuticalReview/~4/W3MGMxoeTQY" height="1" width="1"/&gt;</description> <wfw:commentRss>http://www.europeanpharmaceuticalreview.com/10977/whitepapers/whitepaper-autoantibody-biomarker-panels-for-improved-disease-diagnosis/feed/</wfw:commentRss> <slash:comments>0</slash:comments> <feedburner:origLink>http://www.europeanpharmaceuticalreview.com/10977/whitepapers/whitepaper-autoantibody-biomarker-panels-for-improved-disease-diagnosis/</feedburner:origLink></item> <item><title>Private and public partners unite to combat 10 neglected tropical diseases by 2020</title><link>http://feedproxy.google.com/~r/EuropeanPharmaceuticalReview/~3/_iCSX8v8UcA/</link> <comments>http://www.europeanpharmaceuticalreview.com/10952/news/industry-news/private-and-public-partners-unite-to-combat-10-neglected-tropical-diseases-by-2020/#comments</comments> <pubDate>Mon, 30 Jan 2012 17:15:37 +0000</pubDate> <dc:creator>pmccartney</dc:creator> <category><![CDATA[Industry news]]></category> <category><![CDATA[News]]></category> <category><![CDATA[Alexandre Manguele]]></category> <category><![CDATA[Andrew Witty]]></category> <category><![CDATA[Bill Gates]]></category> <category><![CDATA[Margaret Chan]]></category> <category><![CDATA[Pfizer]]></category> <category><![CDATA[Stephen O'Brien]]></category> <category><![CDATA[World Health Organization (WHO)]]></category><guid isPermaLink="false">http://www.europeanpharmaceuticalreview.com/?p=10952</guid> <description>Partners pledge innovative, coordinated action aimed at new WHO goals...&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/EuropeanPharmaceuticalReview?a=_iCSX8v8UcA:7pz3q6ylHyU:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/EuropeanPharmaceuticalReview?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/EuropeanPharmaceuticalReview?a=_iCSX8v8UcA:7pz3q6ylHyU:qj6IDK7rITs"&gt;&lt;img src="http://feeds.feedburner.com/~ff/EuropeanPharmaceuticalReview?d=qj6IDK7rITs" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/EuropeanPharmaceuticalReview/~4/_iCSX8v8UcA" height="1" width="1"/&gt;</description> <wfw:commentRss>http://www.europeanpharmaceuticalreview.com/10952/news/industry-news/private-and-public-partners-unite-to-combat-10-neglected-tropical-diseases-by-2020/feed/</wfw:commentRss> <slash:comments>0</slash:comments> <feedburner:origLink>http://www.europeanpharmaceuticalreview.com/10952/news/industry-news/private-and-public-partners-unite-to-combat-10-neglected-tropical-diseases-by-2020/</feedburner:origLink></item> <item><title>Novartis extends commitment to help achieve final elimination of leprosy</title><link>http://feedproxy.google.com/~r/EuropeanPharmaceuticalReview/~3/wzkaOIU-IJM/</link> <comments>http://www.europeanpharmaceuticalreview.com/10950/news/industry-news/novartis-extends-commitment-to-help-achieve-final-elimination-of-leprosy/#comments</comments> <pubDate>Mon, 30 Jan 2012 17:10:14 +0000</pubDate> <dc:creator>pmccartney</dc:creator> <category><![CDATA[Industry news]]></category> <category><![CDATA[News]]></category> <category><![CDATA[Joseph Jimenez]]></category> <category><![CDATA[Novartis]]></category> <category><![CDATA[World Health Organization (WHO)]]></category><guid isPermaLink="false">http://www.europeanpharmaceuticalreview.com/?p=10950</guid> <description>Novartis is a part of an international effort to eliminate or control 10 NTDs by the end of the decade...&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/EuropeanPharmaceuticalReview?a=wzkaOIU-IJM:leV-Fn5lMmc:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/EuropeanPharmaceuticalReview?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/EuropeanPharmaceuticalReview?a=wzkaOIU-IJM:leV-Fn5lMmc:qj6IDK7rITs"&gt;&lt;img src="http://feeds.feedburner.com/~ff/EuropeanPharmaceuticalReview?d=qj6IDK7rITs" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/EuropeanPharmaceuticalReview/~4/wzkaOIU-IJM" height="1" width="1"/&gt;</description> <wfw:commentRss>http://www.europeanpharmaceuticalreview.com/10950/news/industry-news/novartis-extends-commitment-to-help-achieve-final-elimination-of-leprosy/feed/</wfw:commentRss> <slash:comments>0</slash:comments> <feedburner:origLink>http://www.europeanpharmaceuticalreview.com/10950/news/industry-news/novartis-extends-commitment-to-help-achieve-final-elimination-of-leprosy/</feedburner:origLink></item> <item><title>FDA approves Jentadueto™ (linagliptin/metformin hydrochloride) tablets for the treatment of adult patients with type 2 diabetes</title><link>http://feedproxy.google.com/~r/EuropeanPharmaceuticalReview/~3/YJXWJRmBfAw/</link> <comments>http://www.europeanpharmaceuticalreview.com/10971/news/industry-news/fda-approves-jentadueto-linagliptinmetformin-hydrochloride-tablets-for-the-treatment-of-adult-patients-with-type-2-diabetes/#comments</comments> <pubDate>Mon, 30 Jan 2012 11:12:06 +0000</pubDate> <dc:creator>pmccartney</dc:creator> <category><![CDATA[Industry news]]></category> <category><![CDATA[News]]></category> <category><![CDATA[Boehringer Ingelheim]]></category> <category><![CDATA[David Pass]]></category> <category><![CDATA[Eli Lilly and Company]]></category> <category><![CDATA[Lance Sloan]]></category><guid isPermaLink="false">http://www.europeanpharmaceuticalreview.com/?p=10971</guid> <description>Jentadueto™ tablets approved...&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/EuropeanPharmaceuticalReview?a=YJXWJRmBfAw:tJmZjeGXtys:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/EuropeanPharmaceuticalReview?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/EuropeanPharmaceuticalReview?a=YJXWJRmBfAw:tJmZjeGXtys:qj6IDK7rITs"&gt;&lt;img src="http://feeds.feedburner.com/~ff/EuropeanPharmaceuticalReview?d=qj6IDK7rITs" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/EuropeanPharmaceuticalReview/~4/YJXWJRmBfAw" height="1" width="1"/&gt;</description> <wfw:commentRss>http://www.europeanpharmaceuticalreview.com/10971/news/industry-news/fda-approves-jentadueto-linagliptinmetformin-hydrochloride-tablets-for-the-treatment-of-adult-patients-with-type-2-diabetes/feed/</wfw:commentRss> <slash:comments>0</slash:comments> <feedburner:origLink>http://www.europeanpharmaceuticalreview.com/10971/news/industry-news/fda-approves-jentadueto-linagliptinmetformin-hydrochloride-tablets-for-the-treatment-of-adult-patients-with-type-2-diabetes/</feedburner:origLink></item> <item><title>Biogen Idec appoints Kenneth DiPietro Executive Vice President Human Resources</title><link>http://feedproxy.google.com/~r/EuropeanPharmaceuticalReview/~3/WArLeWWIfvw/</link> <comments>http://www.europeanpharmaceuticalreview.com/10965/news/industry-news/biogen-idec-appoints-kenneth-dipietro-executive-vice-president-human-resources/#comments</comments> <pubDate>Mon, 30 Jan 2012 10:57:04 +0000</pubDate> <dc:creator>pmccartney</dc:creator> <category><![CDATA[Industry news]]></category> <category><![CDATA[News]]></category> <category><![CDATA[Biogen Idec]]></category> <category><![CDATA[George A. Scangos]]></category> <category><![CDATA[Kenneth DiPietro]]></category><guid isPermaLink="false">http://www.europeanpharmaceuticalreview.com/?p=10965</guid> <description>Kenneth DiPietro named Executive Vice President, Human Resources...&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/EuropeanPharmaceuticalReview?a=WArLeWWIfvw:CZZP7avORGo:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/EuropeanPharmaceuticalReview?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/EuropeanPharmaceuticalReview?a=WArLeWWIfvw:CZZP7avORGo:qj6IDK7rITs"&gt;&lt;img src="http://feeds.feedburner.com/~ff/EuropeanPharmaceuticalReview?d=qj6IDK7rITs" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/EuropeanPharmaceuticalReview/~4/WArLeWWIfvw" height="1" width="1"/&gt;</description> <wfw:commentRss>http://www.europeanpharmaceuticalreview.com/10965/news/industry-news/biogen-idec-appoints-kenneth-dipietro-executive-vice-president-human-resources/feed/</wfw:commentRss> <slash:comments>0</slash:comments> <feedburner:origLink>http://www.europeanpharmaceuticalreview.com/10965/news/industry-news/biogen-idec-appoints-kenneth-dipietro-executive-vice-president-human-resources/</feedburner:origLink></item> <item><title>Sanofi commits to eliminate or control five neglected tropical diseases</title><link>http://feedproxy.google.com/~r/EuropeanPharmaceuticalReview/~3/uewcPSORUkc/</link> <comments>http://www.europeanpharmaceuticalreview.com/10958/news/industry-news/sanofi-commits-to-eliminate-or-control-five-neglected-tropical-diseases/#comments</comments> <pubDate>Mon, 30 Jan 2012 10:33:46 +0000</pubDate> <dc:creator>pmccartney</dc:creator> <category><![CDATA[Industry news]]></category> <category><![CDATA[News]]></category> <category><![CDATA[Christopher A. Viehbacher]]></category> <category><![CDATA[Sanofi]]></category> <category><![CDATA[World Health Organization (WHO)]]></category><guid isPermaLink="false">http://www.europeanpharmaceuticalreview.com/?p=10958</guid> <description>These commitments are a key part of the "Uniting to Combat Neglected Tropical Diseases" partnership...&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/EuropeanPharmaceuticalReview?a=uewcPSORUkc:uNDjyRAp6no:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/EuropeanPharmaceuticalReview?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/EuropeanPharmaceuticalReview?a=uewcPSORUkc:uNDjyRAp6no:qj6IDK7rITs"&gt;&lt;img src="http://feeds.feedburner.com/~ff/EuropeanPharmaceuticalReview?d=qj6IDK7rITs" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/EuropeanPharmaceuticalReview/~4/uewcPSORUkc" height="1" width="1"/&gt;</description> <wfw:commentRss>http://www.europeanpharmaceuticalreview.com/10958/news/industry-news/sanofi-commits-to-eliminate-or-control-five-neglected-tropical-diseases/feed/</wfw:commentRss> <slash:comments>0</slash:comments> <feedburner:origLink>http://www.europeanpharmaceuticalreview.com/10958/news/industry-news/sanofi-commits-to-eliminate-or-control-five-neglected-tropical-diseases/</feedburner:origLink></item> <item><title>FDA approves Erivedge (vismodegib) capsule</title><link>http://feedproxy.google.com/~r/EuropeanPharmaceuticalReview/~3/2I5dtm1vqyk/</link> <comments>http://www.europeanpharmaceuticalreview.com/10955/news/industry-news/fda-approves-erivedge-vismodegib-capsule/#comments</comments> <pubDate>Mon, 30 Jan 2012 10:27:51 +0000</pubDate> <dc:creator>pmccartney</dc:creator> <category><![CDATA[Industry news]]></category> <category><![CDATA[News]]></category> <category><![CDATA[Food and Drug Administration (FDA)]]></category> <category><![CDATA[Hal Barron]]></category> <category><![CDATA[Roche]]></category><guid isPermaLink="false">http://www.europeanpharmaceuticalreview.com/?p=10955</guid> <description>The first medicine for adults with advanced basal cell carcinoma...&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/EuropeanPharmaceuticalReview?a=2I5dtm1vqyk:zgzjZ-oxfbk:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/EuropeanPharmaceuticalReview?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/EuropeanPharmaceuticalReview?a=2I5dtm1vqyk:zgzjZ-oxfbk:qj6IDK7rITs"&gt;&lt;img src="http://feeds.feedburner.com/~ff/EuropeanPharmaceuticalReview?d=qj6IDK7rITs" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/EuropeanPharmaceuticalReview/~4/2I5dtm1vqyk" height="1" width="1"/&gt;</description> <wfw:commentRss>http://www.europeanpharmaceuticalreview.com/10955/news/industry-news/fda-approves-erivedge-vismodegib-capsule/feed/</wfw:commentRss> <slash:comments>0</slash:comments> <feedburner:origLink>http://www.europeanpharmaceuticalreview.com/10955/news/industry-news/fda-approves-erivedge-vismodegib-capsule/</feedburner:origLink></item> </channel> </rss><!-- Performance optimized by W3 Total Cache. Learn more: http://www.w3-edge.com/wordpress-plugins/

Minified using disk: basic
Database Caching 24/28 queries in 0.046 seconds using disk: basic
Object Caching 882/887 objects using disk: basic

Served from: www.europeanpharmaceuticalreview.com @ 2012-02-04 19:58:38 -->

